4/A: Omega Healthcare Investors Executive Purchases Shares Through Employee Stock Purchase Plan
SEC Form 4/A Filing
Neal Ballew, Chief Accounting Officer of Omega Healthcare Investors, acquired 215 shares of common stock through the company's Employee Stock Purchase Plan at a price of $29.12 per share.
Summary
- On October 1, 2024, Neal Ballew, Chief Accounting Officer of Omega Healthcare Investors, purchased 215 shares of the company's common stock.
- The shares were acquired through the Employee Stock Purchase Plan (ESPP) at a price of $29.12 per share.
- Following the transaction, Ballew directly owns 3,462 shares of Omega Healthcare Investors.
- An amendment was filed to correct an error in the sales price of the shares purchased under the ESPP.
- Ballew has a power of attorney designating Robert O. Stephenson, Gail D. Makode, Thomas H. Peterson, and Meghan C. Lyons to act on his behalf for SEC filings related to company stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction, and the amendment is simply a correction of a previous error. Executive participation in the ESPP is a mild positive.
Positives
- Executive participation in the Employee Stock Purchase Plan can be seen as a positive sign of confidence in the company's future.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future performance.
Comparison to Industry Standards
- Executive stock purchases are common across publicly traded companies, often facilitated through ESPPs or stock option grants.
- The size and frequency of these purchases vary widely depending on the company's size, industry, and executive compensation structure.
- Comparing Ballew's holdings and transactions to those of executives at similar healthcare REITs like Welltower (WELL) or Ventas (VTR) could provide additional context.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 2022-02-09 | Date of Power of Attorney execution. |
| 2024-10-01 | Date of stock purchase transaction. |
| 2024-10-01 | Date of original Form 4 filing. |
| 2024-10-02 | Date of Form 4/A filing (amendment). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.